These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 21550021)

  • 1. The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder.
    Del Campo N; Chamberlain SR; Sahakian BJ; Robbins TW
    Biol Psychiatry; 2011 Jun; 69(12):e145-57. PubMed ID: 21550021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways.
    Arnsten AF
    J Clin Psychiatry; 2006; 67 Suppl 8():7-12. PubMed ID: 16961424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update.
    Prince J
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S39-45. PubMed ID: 18480676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
    Wilens TE
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional dysconnectivity of corticostriatal circuitry and differential response to methylphenidate in youth with attention-deficit/hyperactivity disorder.
    Hong SB; Harrison BJ; Fornito A; Sohn CH; Song IC; Kim JW
    J Psychiatry Neurosci; 2015 Jan; 40(1):46-57. PubMed ID: 25266402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing computational models of dopamine and noradrenaline dysfunction in attention deficit/hyperactivity disorder.
    Frank MJ; Santamaria A; O'Reilly RC; Willcutt E
    Neuropsychopharmacology; 2007 Jul; 32(7):1583-99. PubMed ID: 17164816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of methylphenidate on neural systems of attention in attention deficit hyperactivity disorder.
    Shafritz KM; Marchione KE; Gore JC; Shaywitz SE; Shaywitz BA
    Am J Psychiatry; 2004 Nov; 161(11):1990-7. PubMed ID: 15514398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.
    Volkow ND; Wang GJ; Newcorn J; Telang F; Solanto MV; Fowler JS; Logan J; Ma Y; Schulz K; Pradhan K; Wong C; Swanson JM
    Arch Gen Psychiatry; 2007 Aug; 64(8):932-40. PubMed ID: 17679638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Towards an understanding of the molecular mechanisms underlying the pharmacological treatments of attention deficit hyperactivity disorder].
    Castellanos FX; Acosta MT
    Rev Neurol; 2011 Mar; 52 Suppl 1():S155-60. PubMed ID: 21365598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder.
    Rosa-Neto P; Lou HC; Cumming P; Pryds O; Karrebaek H; Lunding J; Gjedde A
    Neuroimage; 2005 Apr; 25(3):868-76. PubMed ID: 15808987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment.
    del Campo N; Fryer TD; Hong YT; Smith R; Brichard L; Acosta-Cabronero J; Chamberlain SR; Tait R; Izquierdo D; Regenthal R; Dowson J; Suckling J; Baron JC; Aigbirhio FI; Robbins TW; Sahakian BJ; Müller U
    Brain; 2013 Nov; 136(Pt 11):3252-70. PubMed ID: 24163364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiating frontostriatal and fronto-cerebellar circuits in attention-deficit/hyperactivity disorder.
    Durston S; van Belle J; de Zeeuw P
    Biol Psychiatry; 2011 Jun; 69(12):1178-84. PubMed ID: 20965496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of stimulants in attention-deficit/hyperactivity disorder.
    Stahl SM
    J Clin Psychiatry; 2010 Jan; 71(1):12-3. PubMed ID: 20129003
    [No Abstract]   [Full Text] [Related]  

  • 14. Striatal creatine and glutamate/glutamine in attention-deficit/hyperactivity disorder.
    Carrey NJ; MacMaster FP; Gaudet L; Schmidt MH
    J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):11-7. PubMed ID: 17343550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulant treatment history predicts frontal-striatal structural connectivity in adolescents with attention-deficit/hyperactivity disorder.
    Schweren LJ; Hartman CA; Zwiers MP; Heslenfeld DJ; Franke B; Oosterlaan J; Buitelaar JK; Hoekstra PJ
    Eur Neuropsychopharmacol; 2016 Apr; 26(4):674-83. PubMed ID: 26899587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulants: Therapeutic actions in ADHD.
    Arnsten AF
    Neuropsychopharmacology; 2006 Nov; 31(11):2376-83. PubMed ID: 16855530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translational approaches to frontostriatal dysfunction in attention-deficit/hyperactivity disorder using a computerized neuropsychological battery.
    Chamberlain SR; Robbins TW; Winder-Rhodes S; Müller U; Sahakian BJ; Blackwell AD; Barnett JH
    Biol Psychiatry; 2011 Jun; 69(12):1192-203. PubMed ID: 21047621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.
    Rubia K; Halari R; Cubillo A; Mohammad AM; Brammer M; Taylor E
    Neuropharmacology; 2009 Dec; 57(7-8):640-52. PubMed ID: 19715709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofunctional effects of methylphenidate and atomoxetine in boys with attention-deficit/hyperactivity disorder during time discrimination.
    Smith A; Cubillo A; Barrett N; Giampietro V; Simmons A; Brammer M; Rubia K
    Biol Psychiatry; 2013 Oct; 74(8):615-22. PubMed ID: 23731741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADHD-related sex differences in fronto-subcortical intrinsic functional connectivity and associations with delay discounting.
    Rosch KS; Mostofsky SH; Nebel MB
    J Neurodev Disord; 2018 Dec; 10(1):34. PubMed ID: 30541434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.